Home › Trial NCT00625430
A Phase I Gene Therapy Study of FP253/Fludarabine for Prostate Cancer
- Trial IDNCT00625430
- StatusUnknown
- PhasePhase 1
- Study typeInterventional
- SponsorBiotech Equity Partners Pty Ltd
- Enrollment18
- Start date2008-03
- ConditionsProstate Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.